BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2952583)

  • 1. Relative cloning efficiencies and long-term propagation capacity for T cell clones of highly purified natural interleukin 2 compared to recombinant interleukin 2 in man.
    Pawelec G; Schwuléra U; Blaurock M; Busch FW; Rehbein A; Balko I; Wernet P
    Immunobiology; 1987 Jan; 174(1):67-75. PubMed ID: 2952583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of functional human T lymphocytes by limiting dilution: impact of filler cells and interleukin 2 sources on cloning efficiencies.
    Kahle P; Wernet P; Rehbein A; Kumbier I; Pawelec G
    Scand J Immunol; 1981 Nov; 14(5):493-502. PubMed ID: 6278580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2- and mitogen-activated NK-like killer cells from highly purified human peripheral blood T cell (CD3+ N901-) cultures.
    Atzpodien J; Wisniewski D; Gulati S; Welte K; Knowles R; Clarkson B
    Nat Immun Cell Growth Regul; 1987; 6(3):129-40. PubMed ID: 3114621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine growth of T cells independent of interleukin 2: identification of interleukin 4 (IL 4, BSF-1) as an autocrine growth factor for a cloned antigen-specific helper T cell.
    Kupper T; Horowitz M; Lee F; Robb R; Flood PM
    J Immunol; 1987 Jun; 138(12):4280-7. PubMed ID: 2953803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4.
    Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H
    J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones.
    Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE
    J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels.
    Ferrini S; Miescher S; Zocchi MR; von Fliedner V; Moretta A
    J Immunol; 1987 Feb; 138(4):1297-302. PubMed ID: 3100633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 production and response by helper T-cell subsets in man.
    Salmon M; Kitas GD; Gaston JS; Bacon PA
    Immunology; 1988 Sep; 65(1):81-5. PubMed ID: 2972603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
    Damle NK; Doyle LV; Bradley EC
    J Immunol; 1986 Nov; 137(9):2814-22. PubMed ID: 2944965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative effect of IFN-gamma in immune regulation. III. Differential selection of TH1 and TH2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFN-gamma.
    Gajewski TF; Joyce J; Fitch FW
    J Immunol; 1989 Jul; 143(1):15-22. PubMed ID: 2525146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. rIL 2-induced proliferation of human circulating NK cells and T lymphocytes: synergistic effects of IL 1 and IL 2.
    Ben Aribia MH; Leroy E; Lantz O; Métivier D; Autran B; Charpentier B; Hercend T; Senik A
    J Immunol; 1987 Jul; 139(2):443-51. PubMed ID: 3110271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
    London L; Perussia B; Trinchieri G
    J Immunol; 1986 Dec; 137(12):3845-54. PubMed ID: 3491151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human epidermal cells from ultraviolet light-exposed skin preferentially activate autoreactive CD4+2H4+ suppressor-inducer lymphocytes and CD8+ suppressor/cytotoxic lymphocytes.
    Baadsgaard O; Fox DA; Cooper KD
    J Immunol; 1988 Mar; 140(6):1738-44. PubMed ID: 2964481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helper-independent CD8+ cytotoxic T lymphocytes express IL-1 receptors and require IL-1 for secretion of IL-2.
    Klarnet JP; Kern DE; Dower SK; Matis LA; Cheever MA; Greenberg PD
    J Immunol; 1989 Apr; 142(7):2187-91. PubMed ID: 2466890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant IL 2 but not recombinant interferon-gamma stimulates both proliferation and IgM secretion in a Ly-1+ clone of neoplastic murine B cells (BCL1).
    Brooks KH; Vitetta ES
    J Immunol; 1986 Nov; 137(10):3205-10. PubMed ID: 2945863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signal requirements for the generation of T-lymphocytes from T-depleted bone marrow cells: a sequential study.
    Lecron JC; Mossalayi MD; Tanzer J; Gomert J; Goube de Laforest P
    Exp Hematol; 1989 Aug; 17(7):785-90. PubMed ID: 2473913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells.
    Street NE; Schumacher JH; Fong TA; Bass H; Fiorentino DF; Leverah JA; Mosmann TR
    J Immunol; 1990 Mar; 144(5):1629-39. PubMed ID: 1968485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of lymphokine activities and helper function for IgE in human T cell clones.
    Maggi E; Del Prete G; Macchia D; Parronchi P; Tiri A; Chrétien I; Ricci M; Romagnani S
    Eur J Immunol; 1988 Jul; 18(7):1045-50. PubMed ID: 2969818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.